Published in J Clin Oncol on February 01, 1995
Thiopurine Enhanced ALL Maintenance Therapy (TEAM) | NCT02912676
Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia. Blood (2011) 1.88
Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia. J Clin Oncol (2015) 1.84
6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study. Blood (2014) 1.70
Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study. JAMA Oncol (2015) 1.55
Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Leukemia (2008) 1.33
Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy. Br J Clin Pharmacol (2011) 1.29
Therapeutic drug monitoring of antimetabolic cytotoxic drugs. Br J Clin Pharmacol (1999) 1.06
Treatment of pediatric acute lymphoblastic leukemia. Pediatr Clin North Am (2014) 1.04
Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia. Eur J Clin Pharmacol (2012) 1.03
Implementation of TPMT testing. Br J Clin Pharmacol (2014) 0.96
Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction. J Pediatr Hematol Oncol (2014) 0.95
Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine. Br J Clin Pharmacol (2008) 0.95
NUDT15 gene polymorphism related to mercaptopurine intolerance in Taiwan Chinese children with acute lymphoblastic leukemia. Pharmacogenomics J (2015) 0.87
A grounded theory of the process of adherence to oral chemotherapy in Hispanic and caucasian children and adolescents with acute lymphoblastic leukemia. J Pediatr Oncol Nurs (2011) 0.86
Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics. Br J Haematol (2014) 0.86
Profile of non-compliance in lymphoblastic leukaemia. Arch Dis Child (1997) 0.86
Model-Based Individualized Treatment of Chemotherapeutics: Bayesian Population Modeling and Dose Optimization. PLoS One (2015) 0.82
Thiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003. Br J Haematol (2015) 0.81
Maintenance treatment and shared care in lymphoblastic leukaemia. Arch Dis Child (1995) 0.77
Clinical implication of thiopurine methyltransferase polymorphism in children with acute lymphoblastic leukemia: A preliminary Egyptian study. Indian J Med Paediatr Oncol (2016) 0.75
Promising approaches in acute leukemia. Invest New Drugs (2000) 0.75
Chemotherapy individualization. Invest New Drugs (2003) 0.75
Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia (2009) 2.11
Risk of acute childhood leukaemia in Sweden after the Chernobyl reactor accident. Swedish Child Leukaemia Group. BMJ (1994) 2.03
Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med (2000) 1.91
Childhood leukaemia in Sweden: using GIS and a spatial scan statistic for cluster detection. Stat Med (1997) 1.82
Randomized clinical trial of laparoscopic gastric bypass versus laparoscopic duodenal switch for superobesity. Br J Surg (2010) 1.71
Radiation sensitivity of endometrial carcinoma in vitro. Gynecol Oncol (1992) 1.41
Non-Hodgkin lymphoma in children: a 20-year population-based epidemiologic study in western Sweden. J Pediatr Hematol Oncol (1999) 1.39
Radiation-induced brachial plexopathy: neurological follow-up in 161 recurrence-free breast cancer patients. Int J Radiat Oncol Biol Phys (1993) 1.38
Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Leukemia (2008) 1.33
Autosomal dominant progressive external ophthalmoplegia with multiple deletions of mtDNA: clinical, biochemical, and molecular genetic features of the 10q-linked disease. Neurology (1997) 1.23
Outcome after lung cancer surgery. Factors predicting early mortality and major morbidity. Eur J Cardiothorac Surg (2001) 1.23
Long-term prognosis in childhood epilepsy: survival and seizure prognosis. Epilepsia (1987) 1.19
Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials. Leukemia (2005) 1.18
Faecal calprotectin: a novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol (1993) 1.13
Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism. Cancer (1999) 1.13
Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia (2000) 1.08
Transient erythroblastopenia in infancy and childhood. Scand J Haematol (1970) 1.06
Detection and assessment of clusters of disease: an application to nuclear power plant facilities and childhood leukaemia in Sweden. Stat Med (1995) 1.05
Cancer incidence in the first-degree relatives of ovarian cancer patients. Br J Cancer (1996) 1.03
Deletion of the Ink4-locus (the p16ink4a, p14ARF and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92. Leukemia (2002) 1.03
Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO). Med Pediatr Oncol (1995) 1.03
Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease. Pharmacol Toxicol (1999) 1.03
G(2) chromosomal radiosensitivity in Danish survivors of childhood and adolescent cancer and their offspring. Br J Cancer (2005) 1.00
Borderline ovarian tumors in Finland: epidemiology and familial occurrence. Am J Epidemiol (1996) 0.99
The effect of physical training on skeletal muscle in patients with chronic heart failure. Eur J Heart Fail (2000) 0.99
No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission. J Clin Oncol (2001) 0.99
Genetic susceptibility to multiple sclerosis. A co-twin study of a nationwide series. Arch Neurol (1988) 0.98
Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac: pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system. Br J Haematol (2001) 0.98
Cat-scratch disease manifesting as unifocal helioid choroiditis. Arch Ophthalmol (1998) 0.97
Problems in anlysis of faecal sugar. Arch Dis Child (1976) 0.96
Health and persistent functional late effects in adult survivors of childhood CNS tumours: a population-based cohort study. Eur J Cancer (2009) 0.96
Periodic breathing and hypoxia in snorers and controls: validation of snoring history and association with blood pressure and obesity. Acta Neurol Scand (1987) 0.96
Identification of microdeletions spanning the Diamond-Blackfan anemia locus on 19q13 and evidence for genetic heterogeneity. Am J Hum Genet (1998) 0.96
Nasal-CPAP, surgery, and conservative management for treatment of obstructive sleep apnea syndrome. A randomized study. Chest (1996) 0.95
Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery. Drug Deliv (2007) 0.94
Bilateral diaphragmatic weakness: a late complication of radiotherapy. Thorax (1997) 0.94
Transient effect of L-tryptophan in progressive myoclonus epilepsy without Lafora bodies: clinical and electrophysiological study. Epilepsia (1980) 0.94
A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method. Scand J Gastroenterol (2001) 0.94
Iron and iron/manganese ratio in forage from Icelandic sheep farms: relation to scrapie. Acta Vet Scand (2006) 0.93
Cellular cytotoxic drug sensitivity in children with acute leukemia and Down's syndrome: an explanation to differences in clinical outcome? Leukemia (2000) 0.93
Fungi carried from farmers' work into farm homes. Am Ind Hyg Assoc J (1989) 0.93
Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden. Haemophilia (2004) 0.93
Disseminated fungal disease resistant to fluconazole treatment in a child with leukemia. Scand J Infect Dis (1992) 0.93
Mesoporous silica material TUD-1 as a drug delivery system. Int J Pharm (2006) 0.91
Cognitive function in middle-aged snorers and controls: role of excessive daytime somnolence and sleep-related hypoxic events. Sleep (1988) 0.91
Risk factors in endometrial carcinoma with special reference to the use of estrogens. Acta Obstet Gynecol Scand Suppl (1979) 0.91
Copper, ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease . a case-control study. Dement Geriatr Cogn Disord (1998) 0.91
A population-based study of childhood acute lymphoblastic leukemia diagnosed from July 1981 through June 1985 in the five Nordic countries. Incidence, patient characteristics and treatment results. Acta Paediatr Scand (1987) 0.90
Higher risk for acute childhood lymphoblastic leukaemia in Swedish population centres 1973-94. Swedish Child Leukaemia Group. Br J Cancer (1999) 0.90
Genetics of congenital nemaline myopathy: a study of 10 families. J Med Genet (1990) 0.90
Large atypical polyps of the vagina during pregnancy with concomitant human papilloma virus infection. Eur J Obstet Gynecol Reprod Biol (1988) 0.90
Impact of morning versus evening schedule for oral methotrexate and 6-mercaptopurine on relapse risk for children with acute lymphoblastic leukemia. Nordic Society for Pediatric Hematology and Oncology (NOPHO). J Pediatr Hematol Oncol (1997) 0.89
Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries. Br J Clin Pharmacol (2001) 0.88
Axial myopathy--an unrecognised entity. J Neurol (2002) 0.88
Acute lymphoblastic leukemia in adolescents between 10 and 19 years of age in Denmark--secondary publication. Dan Med Bull (2006) 0.88
Drugged driving in the Nordic countries--a comparative study between five countries. Forensic Sci Int (1999) 0.88
Automatic analysis of sleep records with static charge sensitive bed. Electroencephalogr Clin Neurophysiol (1986) 0.87
Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation. Acta Paediatr Scand (1987) 0.87
Pharmacokinetics of Erwinia asparaginase after intravenous and intramuscular administration. Cancer Chemother Pharmacol (2001) 0.87
Pure red-cell anaemia with pro-erythroblast maturation arrest. Scand J Haematol (1970) 0.87
Is there a role for interleukin-3 in Diamond-Blackfan anaemia? Results of a European multicentre study. Br J Haematol (1995) 0.87
The degree of myelosuppression during maintenance therapy of adolescents with B-lineage intermediate risk acute lymphoblastic leukemia predicts risk of relapse. Leukemia (2010) 0.87
Cellular immune defects to Epstein-Barr virus-determined antigens in young males. Cancer Res (1981) 0.87
Copper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down's syndrome. Pharmacol Toxicol (2001) 0.87
Prognostic impact of bone marrow karyotype in childhood acute lymphoblastic leukaemia: Swedish experiences 1986-91. Acta Paediatr (1997) 0.86
Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools. Scand J Infect Dis (1991) 0.86
Fatal poisoning in drug addicts in the Nordic countries. Forensic Sci Int (2001) 0.86
Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: a population-based case control study from the Nordic countries. Bone Marrow Transplant (1999) 0.85
Radio and plasma wave observations at Saturn from Cassini's approach and first orbit. Science (2004) 0.85
Nocturnal oxygen saturation in advanced chronic obstructive pulmonary disease after a moderate dose of ethanol. Eur Respir J (1992) 0.85
Severe aplastic anaemia in the Nordic countries: a population based study of incidence, presentation, course, and outcome. Arch Dis Child (1996) 0.85
Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineage. Br J Haematol (2005) 0.84
On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome. Haemophilia (2003) 0.84
Clinical trial: gluten microchallenge with wheat-based starch hydrolysates in coeliac disease patients - a randomized, double-blind, placebo-controlled study to evaluate safety. Aliment Pharmacol Ther (2008) 0.84
Feulgen DNA values in Wilms' tumour in relation to prognosis. Pathol Res Pract (1988) 0.84
Long-term survival and quality of life in patients treated with a national all protocol 15-20 years earlier: IDM/HDM and late effects? Pediatr Hematol Oncol (1997) 0.84
Automatic analysis of static charge sensitive bed (SCSB) recordings in the evaluation of sleep-related apneas. Acta Neurol Scand (1986) 0.83
Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation. Pediatr Blood Cancer (2004) 0.83
Cerebral irradiation causes blunted pubertal growth in girls treated for acute leukemia. Med Pediatr Oncol (1994) 0.83
Cassini measurements of cold plasma in the ionosphere of Titan. Science (2005) 0.83
Cellular and humoral immunity in Hodgkin's disease. I Patients in continuous long-term remission. Scand J Haematol (1981) 0.83
Hypoglycaemia in childhood diabetes. II. Effect of subcutaneous or intramuscular injection of different doses of glucagon. Acta Paediatr Scand (1988) 0.83
Palatal myoclonus and clicking tinnitus in a 12-year-old girl--case report. Acta Otolaryngol Suppl (2000) 0.83
Allogeneic hematopoietic SCT for alpha-mannosidosis: an analysis of 17 patients. Bone Marrow Transplant (2011) 0.82